Development of an ELISA detecting Tumor Protein 53-Induced Nuclear Protein 1 in serum of prostate cancer patients

Results in Immunology

Volumn 3, Issue , 2013, Pages 51-56

  Saadi, Houda ^a,b,c,d,e,f   Seillier, Marion ^a,b,c,d   Sandi, Maria José ^a,b,c,d   Peuget, Sylvain ^a,b,c,d   Kellenberger, Christine ^c,g   Gravis, Gwenaëlle ^b   Dusetti, Nelson J ^a,b,c,d   Iovanna, Juan L ^a,b,c,d   Rocchi, Palma ^a,b,c,d   Amri, Mohamed ^c,f   Carrier, Alice ^a,b,c,d  

^a AIX MARSEILLE UNIVERSITY   (France)

^b INSTITUT PAOLI CALMETTES   (France)

^c AIX MARSEILLE UNIVERSITY   (France)

^d CNRS   (France)

^e Laboratory of Physiology of the Nutrition   (Tunisia)

^f FACULTÉ DES SCIENCES DE TUNIS   (Tunisia)

^g Centre National de la Recherche Scientifique   (France)

Author keywords

Biomarker; ELISA; P53; Prostate cancer; TP53INP1

Indexed keywords

MONOCLONAL ANTIBODY; RECOMBINANT PROTEIN; TUMOR MARKER; TUMOR PROTEIN; TUMOR PROTEIN 53 INDUCED NUCLEAR PROTEIN 1; UNCLASSIFIED DRUG;

ARTICLE; BODY FLUID; CANCER RECURRENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; MICROPLATE READER; MOLECULAR THERAPY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROTEIN BLOOD LEVEL; SERUM;

EID: 84878954983     PISSN: None     EISSN: 22112839     Source Type: Journal    
DOI: 10.1016/j.rinim.2013.05.002     Document Type: Article

References (26)

1. Brosh R., Rotter V. When mutants gain new powers: news from the mutant p53 field. Nature Reviews Cancer 2009, 9:701-713.
2. Hainaut P., Wiman K.G. 30 years and a long way into p53 research. Lancet Oncology 2009, 10:913-919.
3. Wu M., Mao C., Chen Q., Cu X.W., Zhang W.S. Serum p53 protein and anti-p53 antibodies are associated with increased cancer risk: a case-control study of 569 patients and 879 healthy controls. Molecular Biology Reports 2010, 37:339-343.
4. Carrier A., Nguyen C., Victorero G., Granjeaud S., Rocha D., Bernard K., Miazek A., Ferrier P., Malissen M., Naquet P., Malissen B., Jordan B.R. Differential gene expression in CD3epsilon- and RAG1-deficient thymuses: definition of a set of genes potentially involved in thymocyte maturation. Immunogenetics 1999, 50:255-270.
5. Carrier A., Wurbel M.A., Mattei M.G., Kissenpfennig A., Malissen M., Malissen B. Chromosomal localization of two mouse genes encoding thymus-specific serine peptidase and thymus-expressed acidic protein. Immunogenetics 2000, 51:984-986.
6. Tomasini R, Samir AA, Vaccaro MI, Pebusque MJ, Dagorn JC, Iovanna JL, Dusetti NJ Molecular and functional characterization of the stress-induced protein (SIP) gene and its two transcripts generated by alternative splicing. SIP induced by stress and promotes cell death. Journal of Biological Chemistry 2001, 276:44185-44192.
7. Tomasini R., Samir A.A., Pebusque M.J., Calvo E.L., Totaro S., Dagorn J.C., Dusetti N.J., Iovanna J.L. P53-dependent expression of the stress-induced protein (SIP). European Journal of Cell Biology 2002, 81:294-301.
8. Tomasini R., Samir A.A., Carrier A., Isnardon D., Cecchinelli B., Soddu S., Malissen B., Dagorn J.C., Iovanna J.L., Dusetti N.J. TP53INP1s and homeodomain-interacting protein kinase-2 (HIPK2) are partners in regulating p53 activity. Journal of Biological Chemistry 2003, 278:37722-37729.
9. Tomasini R., Seux M., Nowak J., Bontemps C., Carrier A., Dagorn J.C., Pebusque M.J., Iovanna J.L., Dusetti N.J. TP53INP1 is a novel p73 target gene that induces cell cycle arrest and cell death by modulating p73 transcriptional activity. Oncogene 2005, 24:8093-8104.
10. Okamura S., Arakawa H., Tanaka T., Nakanishi H., Ng C.C., Taya Y., Monden M., Nakamura Y. p53DINP1, a p53-inducible gene, regulates p53-dependent apoptosis. Molecular Cell 2001, 8:85-94.
11. Seillier M., Peuget S., Gayet O., Gauthier C., N'Guessan P., Monte M., Carrier A., Iovanna J.L., Dusetti N.J. TP53INP1, a tumor suppressor, interacts with LC3 and ATG8-family proteins through the LC3-interacting region (LIR) and promotes autophagy-dependent cell death. Cell Death and Differentiation 2012, 19:1525-1535.
12. Gironella M., Seux M., Xie M.J., Cano C., Tomasini R., Gommeaux J., Garcia S., Nowak J., Yeung M.L., Jeang K.T., Chaix A., Fazli L., Motoo Y., Wang Q., Rocchi P., Russo A., Gleave M., Dagorn J.C., Iovanna J.L., Carrier A., Pebusque M.J., Dusetti N.J. Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:16170-16175.
13. Gommeaux J., Cano C., Garcia S., Gironella M., Pietri S., Culcasi M., Pebusque M.J., Malissen B., Dusetti N., Iovanna J., Carrier A. Colitis and colitis-associated cancer are exacerbated in mice deficient for tumor protein 53-induced nuclear protein 1. Molecular and Cellular Biology 2007, 27:2215-2228.
14. Cano C.E., Gommeaux J., Pietri S., Culcasi M., Garcia S., Seux M., Barelier S., Vasseur S., Spoto R.P., Pebusque M.J., Dusetti N.J., Iovanna J.L., Carrier A. Tumor protein 53-induced nuclear protein 1 is a major mediator of p53 antioxidant function. Cancer Research 2009, 69:219-226.
15. N'Guessan P., Pouyet L., Gosset G., Hamlaoui S., Seillier M., Cano C.E., Seux M., Stocker P., Culcasi M., Iovanna J.L., Dusetti N.J., Pietri S., Carrier A. Absence of tumor suppressor tumor protein 53-induced nuclear protein 1 (TP53INP1) sensitizes mouse thymocytes and embryonic fibroblasts to redox-driven apoptosis. Antioxidants and Redox Signaling 2011, 15:1639-1653.
16. Seux M., Peuget S., Montero M.P., Siret C., Rigot V., Clerc P., Gigoux V., Pellegrino E., Pouyet L., N'Guessan P., Garcia S., Dufresne M., Iovanna J.L., Carrier A., Andre F., Dusetti N.J. TP53INP1 decreases pancreatic cancer cell migration by regulating SPARC expression. Oncogene 2011, 30:3049-3061.
17. Giusiano S., Garcia S., Andrieu C., Dusetti N.J., Bastide C., Gleave M., Taranger-Charpin C., Iovanna J.L., Rocchi P. TP53INP1 overexpression in prostate cancer correlates with poor prognostic factors and is predictive of biological cancer relapse. Prostate 2011, 72:117-128.
18. Giusiano S., Baylot V., Andrieu C., Fazli L., Gleave M., Iovanna J.L., Taranger-Charpin C., Garcia S., Rocchi P. TP53INP1 as new therapeutic target in castration-resistant prostate cancer. Prostate 2011, 72:1286-1294.
19. Carroccio A., Iovanna J.L., Iacono G., Li Pani M., Montalto G., Cavataio F., Marasa L., Barthellemy-Bialas S., Dagorn J.C. Pancreatitis-associated protein in patients with celiac disease: serum levels and immunocytochemical localization in small intestine. Digestion 1997, 58:98-103.
20. Mishima Y., Coste F., Bobezeau V., Hervouet N., Kellenberger C., Roussel A. Expression, purification, crystallization and preliminary X-ray analysis of the N-terminal domain of GNBP3 from Drosophila melanogaster. Acta Crystallographica Section F: Structural Biology and Crystallization Communication 2009, 65:870-873.
21. Ito Y., Motoo Y., Yoshida H., Iovanna J.L., Takamura Y., Miya A., Kuma K., Miyauchi A. Decreased expression of tumor protein p53-induced nuclear protein 1 (TP53INP1) in breast carcinoma. Anticancer Research 2006, 26:4391-4395.
22. Jiang P.H., Motoo Y., Garcia S., Iovanna J.L., Pebusque M.J., Sawabu N. Down-expression of tumor protein p53-induced nuclear protein 1 in human gastric cancer. World Journal of Gastroenterology 2006, 12:691-696.
23. Ma S., Tang K.H., Chan Y.P., Lee T.K., Kwan P.S., Castilho A., Ng I., Man K., Wong N., To K.F., Zheng B.J., Lai P.B., Lo C.M., Chan K.W., Guan X.Y. miR-130b Promotes CD133(+) liver tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein 1. Cell Stem Cell 2010, 7:694-707.
24. Shibuya H., Iinuma H., Shimada R., Horiuchi A., Watanabe T. Clinicopathological and prognostic value of microRNA-21 and microRNA-155 in colorectal cancer. Oncology 2010, 79:313-320.
25. Weng W., Yang Q., Huang M., Qiao Y., Xie Y., Yu Y., jing A., Li Z. c-Myc inhibits TP53INP1 expression via promoter methylation in esophageal carcinoma. Biochemical and Biophysical Research Communications 2011, 405:278-284.
26. Ito Y., Motoo Y., Yoshida H., Iovanna J.L., Nakamura Y., Kuma K., Miyauchi A. High level of tumour protein p53-induced nuclear protein 1 (TP53INP1) expression in anaplastic carcinoma of the thyroid. Pathology 2006, 38:545-547.